A review of biopsychosocial strategies to prevent and overcome early-recognized poor adherence in growth hormone therapy of children

References

• Seeley RD, Stephens TD, Tate P. Anatomy and Physiology, 8th edn. New York: McGraw-Hill, 2008
   Google Scholar
• Bowlby DA, Rapaport R. Safety and efficacy of growth hormone therapy in childhood. Pediatr Endocrinol Rev 2004;2(Suppl 1):68-77
   PubMedGoogle Scholar
• Clayton PE, Cuneo RC, Juul A, et al. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol 2005;152:165-70
   PubMed Web of Science ®Google Scholar
• Wilson TA, Rose SR, Cohen P, et al. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 2003;143:415-21
   PubMed Web of Science ®Google Scholar
• Kornreich L, Horev G, Lazar L, et al. MR findings in hereditary isolated growth hormone deficiency. AJNR Am J Neuroradiol 1997;18:1743-7
   PubMed Web of Science ®Google Scholar
• Norgren S. Adherence remains a challenge for patients receiving growth hormone therapy. Pediatr Endocrinol Rev 2009;6(Suppl 4):545-8
   PubMedGoogle Scholar
• Engel GL. The need for a new medical model: a challenge for biomedicine. Science 1977;196:129-36
   PubMed Web of Science ®Google Scholar
• Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database of Syst Rev 2008, Issue 2; doi: 10.1002/14651858.CD000011.pub3
   PubMed Web of Science ®Google Scholar
• Vermeire E, Hearnshaw H, Van Royen P, et al. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001;26:331-42
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97
   PubMed Web of Science ®Google Scholar
• World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization, 2003
   Google Scholar
• Gold DT, McClung B. Approaches to patient education: emphasizing the long-term value of compliance and persistence. Am J Med 2006;119(4 Suppl 1):S32-7
   PubMed Web of Science ®Google Scholar
• Haverkamp F, Johansson L, Dumas H, et al. Observations of nonadherence to recombinant human growth hormone therapy in clinical practice. Clin Ther 2008;30:307-16
   PubMed Web of Science ®Google Scholar
• Stanhope R, Moyle L, MacSwiney M. Patient knowledge and compliance with growth hormone treatment. Arch Dis Child 1993;68:525
   PubMed Web of Science ®Google Scholar
• Desrosiers P, O'Brien F, Blethen S. Patient outcomes in the GHMonitor: the effect of delivery device on compliance and growth. Pediatr Endocrinol Rev 2005;2(Suppl 3):327-31
   PubMedGoogle Scholar
• Kapoor RR, Burke SA, Sparrow SE, et al. Monitoring of concordance in growth hormone therapy. Arch Dis Child 2008;93:147-8
   PubMed Web of Science ®Google Scholar
• Oyarazabal M, Aliaga M, Chueca M, et al. Multicentre survey on compliance with growth hormone therapy: what can be improved? Acta Pediatr 1998;87:387-91
   PubMed Web of Science ®Google Scholar
• Cramer J, Rosenheck R, Kirk G, et al. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health 2003;6:566-73
   PubMed Web of Science ®Google Scholar
• Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002;288:2880-3
   PubMed Web of Science ®Google Scholar
• Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002;288:462-7
   PubMed Web of Science ®Google Scholar
• Rosenfeld RG, Bakker B. Compliance and persistence in pediatric and adult patients receiving growth hormone therapy. Endocr Pract 2008;14:143-54
   PubMedGoogle Scholar
• Lee JM, Davis MM, Clark SJ, et al. Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature. Arch Pediatr Adolesc Med 2006;160:263-9
   PubMedGoogle Scholar
• Blethen SL, Baptista J, Kuntze J, et al. Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group. J Clin Endocrinol Metab 1997;82:418-20
   PubMed Web of Science ®Google Scholar
• Bakker B, Frane J, Anhalt H, et al. Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children. J Clin Endocrinol Metab 2008;93:352-7
   PubMed Web of Science ®Google Scholar
• GH Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000;85:3990-3
   PubMed Web of Science ®Google Scholar
• Kirk J. Improving adherence to GH therapy with an electronic device: first experience with easypod. Pediatr Endocrinol Rev 2009; (6 Suppl 4):549-52
   PubMedGoogle Scholar
• Kirk J. Developments in growth hormone delivery. Drug Deliv Ther 2010;5:43-7
   Web of Science ®Google Scholar
• Dahlgren J, Veimo D, Johansson L, et al. Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use. Curr Med Res Opin 2007;23:1649-55
   PubMed Web of Science ®Google Scholar
• Fernández-Pérez L, Nóvoa J, Ståhlberg N, et al. The effect of in vivo growth hormone treatment on blood gene expression in adults with growth hormone deficiency reveals potential biomarkers to monitor growth hormone therapy. Clin Endocrinol 2010;72:800-6
   PubMed Web of Science ®Google Scholar
• Christensen T, Fidler C, Bentley A, et al. The cost-effectiveness of somatropin treatment for short children born small for gestational age (SGA) and children with growth hormone deficiency (GHD) in Sweden. J Med Econ 2010;13:168-78
   PubMedGoogle Scholar
• Haverkamp F, Noeker M. ‘Short stature in children - a questionnaire for parents’: a new instrument for growth disorder-specific psychosocial adaptation in children. Qual Life Res 1998;7:447-55
   PubMed Web of Science ®Google Scholar
• Haverkamp F, Eiholzer U, Ranke MB, et al. Symptomatic versus substitution growth hormone therapy in small children: from auxology towards a comprehensive multidimensional assessment of short stature and related interventions. J Pediatr Endocrinol Metab 2000;13:403-8
   PubMed Web of Science ®Google Scholar
• Noeker M, Haverkamp F. Adjustment in conditions with short stature: a conceptual framework. J Pediatr Endocrinol Metab 2000;13:1585-94
   PubMed Web of Science ®Google Scholar
• Vrijens B, Vincze G, Kristanto P, et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008;336:1114-17
   PubMed Web of Science ®Google Scholar
• Modi AC, Morita DA, Glauser TA. One-month adherence in children with new-onset epilepsy: white-coat compliance does not occur. Pediatrics 2008;12:e961-6
   Google Scholar
• McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002;288:2868-79
   PubMed Web of Science ®Google Scholar
• Smith SL, Hindmarsh PC, Brook CG. Compliance with growth hormone treatment - are they getting it? Arch Dis Child 1993;68:91-3
   PubMed Web of Science ®Google Scholar
• Costello K, Kennedy P, Scanzillo J. Recognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long term. Medscape J Med 2008;10:225
   PubMedGoogle Scholar
• Cox D, Stone J. Managing self-injection difficulties in patients with relapsing-remitting multiple sclerosis. J Neurosci Nurs 2006;38:167-71
   PubMedGoogle Scholar
• Wickramasuriya BP, Casey A, Akhtar S et al. Factors determining patient choice of device for GH therapy. Horm Res 2006;65:18-22
   PubMed Web of Science ®Google Scholar
• Ahmed SF, Smith WA, Blamires C. Facilitating and understanding the family’s choice of injection device for growth hormone therapy by using conjoint analysis. Arch Dis Child 2008;93:110-14
   PubMed Web of Science ®Google Scholar
• Dumas H, Panayiotopoulos P, Parker D, et al. Understanding and meeting the needs of those using growth hormone injection devices. BMC Endocr Disord 2006;6:5
   PubMedGoogle Scholar
• Bozzola M, Colle M, Halldin-Stenlid M, et al. Treatment adherence with the easypod™ growth hormone electronic auto-injector and patient acceptance: survey results from 824 children and their parents. BMC Endocr Disord 2011;11:4
   PubMed Web of Science ®Google Scholar
• Arbuthnott A, Sharpe D. The effect of physician-patient collaboration on patient adherence in non-psychiatric medicine. Patient Educ Couns 2009;77:60-7
   PubMed Web of Science ®Google Scholar
• Cutfield WS, Derraik JGB, Gunn AJ, et al. Non-compliance with growth hormone treatment in children is common and impairs linear growth. PLoS One 2011;6:e16223
   PubMed Web of Science ®Google Scholar
• Chapman RH, Ferrufino CP, Kowal SL, et al. The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs. Int J Clin Pract 2010;64:16-81
   Web of Science ®Google Scholar
• Fielding D, Duff A. Compliance with treatment protocols: interventions for children with chronic illness. Arch Dis Child 1999;80:196-200
   PubMed Web of Science ®Google Scholar